iGMDRD50
| Standard Name | CHEMBL | Pubchem CID | KEGG Drug ID | DRUGBANK ID | Drug Status | Drug targets (TTD) | Drug Type |
|---|---|---|---|---|---|---|---|
| Cytarabine | CHEMBL803 CHEMBL1256472 | 6253 | D03637 | DB00987 | Alone | DNC001551 | Small Molecule |
Drug Class:
Anti-Infective AgentsAntimetabolitesAntimetabolites, AntineoplasticAntineoplastic AgentsAntineoplastic and Immunomodulating AgentsAntiviral AgentsArabinonucleosidesCarbohydratesCardiotoxic antineoplastic agentsCytidineGlycosidesHeterocyclic CompoundsHeterocyclic Compounds, 1-RingImmunologic FactorsImmunosuppressive AgentsMyelosuppressive AgentsNoxaeNucleic Acids, Nucleotides, and NucleosidesNucleoside Metabolic InhibitorNucleosidesP-glycoprotein/ABCB1 SubstratesPyrimidine AnaloguesPyrimidine NucleosidesPyrimidinesRibonucleosidesToxic ActionsDrug Pathways:
DNA replicationDrug Synonyms:
Cytarabine hydrochloride (USAN)Drug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
| Gene ID | Gene Name | Model Num. |
|---|---|---|
| 7514 | XPO1 | 1 |
| 103 | ADAR | 1 |
| 64783 | RBM15 | 1 |
| 4170 | MCL1 | 1 |
| 9757 | KMT2B | 2 |
| 5159 | PDGFRB | 1 |
| 4851 | NOTCH1 | 1 |
| 25937 | WWTR1 | 1 |
| 2064 | ERBB2 | 1 |
| 6850 | SYK | 1 |
| 1029 | CDKN2A | 2 |
| 861 | RUNX1 | 1 |
| 7157 | TP53 | 1 |
| 2305 | FOXM1 | 1 |
| 4086 | SMAD1 | 1 |
| 57111 | RAB25 | 1 |
| 54658 | UGT1A1 | 1 |
| 7490 | WT1 | 1 |
| 675 | BRCA2 | 1 |
| 54894 | RNF43 | 1 |
| 6935 | ZEB1 | 1 |
| 10381 | TUBB3 | 1 |
| 7301 | TYRO3 | 1 |
| 2113 | ETS1 | 1 |
| 2648 | KAT2A | 2 |
| 2067 | ERCC1 | 2 |
| 9223 | MAGI1 | 1 |
| 5054 | SERPINE1 | 1 |
Gene in drug-gene network: Network Plot
Models in Cytarabine

